BRL-306

N/A

Report date: 2025/09/01 13:59:42

Base Information

Drug NameBRL-306
Drug Alias NameBRL-306
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBRL Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBRL Medicine Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A